Conditions

A study aims to establish whether bariatric surgery can reduce adverse cardiovascular events. 

Study finds incidence of type 2 diabetes reduced by 32% in participants taking dapagliflozin vs. placebo. 

A recently published study suggests that supplementation with select strains of naturally occurring gut bacteria may improve postprandial glucose control in patients with T2DM.

Central adiposity shows varying effects on blood pressure, LDL cholesterol, and glycemic profile. 

Novel dual GIP and GLP-1 receptor agonist showed promising results for both reduction in A1C and weight loss. 

How safe and effective is the first commercial configuration of a tubeless automated insulin delivery system in children and adults with type 1 diabetes? 

Researchers sought to assess the prevalence and trend of diabetic complications in adult patients over thirty years.

Clinical dietitians and mobile apps play a crucial role in personalizing treatment for patients with gestational diabetes.

Lifestyle management and intervention alongside a once-weekly semaglutide dose of 2.4 mg. can lead to improved weight loss for patients with overweight or obesity.  

Type 1 diabetes mellitus patients with high BMI and hypoglycemia may improve quality of life through dapagliflozin treatment.